Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079599 · ClinicalTrials.gov registry record · Phase 2
L-Carnitine to Treat Fatigue in AIDS Patients
A Phase 2 study, sponsored by National Institute of Nursing Research (NINR).
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT00079599 is a Phase 2 study that has completed, run by National Institute of Nursing Research (NINR). The registered enrollment target is 44 participants.
The verdict
NCT00079599, a Phase 2 study, has completed, sponsored by National Institute of Nursing Research (NINR).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
Patients with AIDS may develop a deficiency of the micronutrient carnitine and such a deficiency may contribute to fatigue in these patients. This study will determine whether carnitine supplementation will improve fatigue and related symptoms in carnitine-deficient patients with AIDS.
Interventions
- OTHER Placebo
- DRUG L-carnitine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2002-11 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00079599
The ClinicalTrials.gov registry entry for NCT00079599 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Nursing Research (NINR), which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00079599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00079599 about?
NCT00079599 is a clinical study titled "L-Carnitine to Treat Fatigue in AIDS Patients". Patients with AIDS may develop a deficiency of the micronutrient carnitine and such a deficiency may contribute to fatigue in these patients. This study will determine whether carnitine supplementation will improve fatigue and related symptoms in carnitine-deficient patients with AIDS.
What is the current status of trial NCT00079599?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2002-11. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00079599?
The interventions under investigation include: Placebo (OTHER), L-carnitine (DRUG).
Who is sponsoring clinical trial NCT00079599?
This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.